Andere Sprachen Ipca Laboratories Limited Bombay S.E.

Aktien

A3DV91

INE571A01038

IPCALAB

Markt geschlossen - Bombay S.E. Andere Börsenplätze 12:00:50 03.05.2024			% 5 Tage	% 1. Jan.
1.336 ^INR	-1,06 %		-0,19 %	+20,01 %

29.03.	Ipca Laboratories Limited gibt das Ausscheiden von Anand T. Kusre als unabhängiger Direktor bekannt	CI
29.03.	Ipca Laboratories Limited ernennt Swati Arvind Patankar zum unabhängigen Direktor	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Ipca Laboratories Limited Announces Cessation of Anand T. Kusre as an Independent Director	29.03.
Ipca Laboratories Limited Appoints Swati Arvind Patankar as an Independent Director	29.03.
Ipca Laboratories Licenses Anti-Cancer Biosimilar Technology to Omexa Formulary	27.03.
Ipca Laboratories Limited Enters into A Technology Transfer Agreement with Omexa Formulary Pvt. Ltd	27.03.
Ipca Laboratories Limited Announces Appointment of Kamal Kishore Seth as the Lead Independent Director	14.02.
Ipca Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14.02.
Ipca Laboratories Limited Declares Interim Dividend for the Financial Year 2023-24	10.11.
Ipca Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	10.11.
Ipca Laboratories' Pithampur Plant Classified as VAI by US FDA	31.10.23
INDIA STOCKS-Indian shares slide on Mideast jitters; ICICI Bank up on earnings beat	23.10.23
Ipca Laboratories Limited Appoints Hitesh Kumar Maheshwari as President R&D (Formulations)	16.10.23
Ipca Laboratories Limited completed the acquisition of 19.29% stake in Unichem Laboratories Limited for INR 6 billion.	08.09.23
Ipca Laboratories' Piparia Manufacturing Plant in India Gets VAI Classification from US FDA	24.08.23
Ipca Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	10.08.23
Ipca Laboratories Acquires 33% Stake in Unichem for INR9.45 Billion	02.08.23
Ipca Laboratories' Indore, India Unit Gets Eight Observations from US FDA Following Inspection	26.06.23
Indian shares set for muted start to week after Russia turmoil	26.06.23
Ipca Laboratories Gets 11 US FDA Observations from Inspection of APIs Manufacturing Unit in Ratlam, India	14.06.23
Ipca Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	29.05.23
Ipca Laboratories' Manufacturing Unit in Gujarat, India Gets Three Observations from US FDA After Inspection	27.04.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Ipca Laboratories Limited Bombay S.E.

Aktien

A3DV91

INE571A01038

IPCALAB

Andere Sprachen

Filter